Related Experiment Video
Updated: Aug 10, 2026
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
[Oxytocin as a neuroprotective strategy in neonates: concept and preclinical evidence]
1Laboratoire du développement, Université de Genève, Genève, Suisse; Inserm U1141, Université Paris Cité, Paris, France; Service de Soins Intensifs Pédiatriques et Néonatologie, Hôpitaux Universitaires de Genève, Genève, Suisse.
Insights
Oxytocin (OT) shows promise for protecting newborns from brain damage caused by prematurity. This neuropeptide may reduce neuroinflammation, offering a potential therapeutic strategy for vulnerable infants.
Area of Science:
- Neuroscience
- Neonatal Medicine
- Pharmacology
Background:
- Perinatal brain injury affects millions of children annually, linked to prematurity and intrauterine growth retardation.
- Current pharmacological interventions for neonatal brain injury have limited clinical success.
- Environmental enrichment positively impacts infant brain development and neurobehavioral outcomes, with oxytocin (OT) as a potential hormonal mediator.
Purpose of the Study:
- To review the role of oxytocin (OT) in newborns.
- To summarize preclinical evidence supporting OT's neuroprotective potential.
- To explore OT's effects on neonatal brain injury and neuroinflammation.
Main Methods:
- Literature review of existing studies on oxytocin in neonates.
- Analysis of preclinical data on OT's neuroprotective mechanisms.
- Discussion of OT's role in perinatal development, attachment, and social behavior.
Main Results:
- Oxytocin (OT) is crucial for perinatal development, parent-child bonding, and social behaviors.
- Preclinical data indicate that both endogenous and synthetic OT can modulate central nervous system inflammatory responses to neonatal insults.
- The long-term effects of synthetic OT administered during labor are also considered.
Conclusions:
- Oxytocin (OT) emerges as a potential therapeutic agent for neonatal neuroprotection.
- OT's neuroprotective effects appear to be mediated, in part, by regulating neuroinflammation.
- Further research into OT administration for neonatal brain injury is warranted.
Objective:
Prematurity and intra-uterine growth retardation are responsible for brain damage associated with various neurocognitive and behavioral disorders in more than 9 million children each year. Most pharmacological strategies aimed at preventing perinatal brain injury have not demonstrated substantial clinical benefits so far. In contrast, enrichment of the newborn's environment appears to have positive effects on brain structure and function, influences newborn hormonal responses, and has lasting neurobehavioral consequences during infancy and adulthood. Oxytocin (OT), a neuropeptide released by the hypothalamus, may represent the hormonal basis for these long-term effects.
Method:
This review of the literature summarizes the knowledge concerning the effect of OT in the newborn and the preclinical data supporting its neuroprotective effect.
Results:
OT plays a role during the perinatal period, in parent-child attachment and in social behavior. Furthermore, preclinical studies strongly suggest that endogenous and synthetic OT is capable of regulating the inflammatory response of the central nervous system in response to situations of prematurity or more generally insults to the developing brain. The long-term effect of synthetic OT administration during labor is also discussed.
Conclusion:
All the conceptual and experimental data converge to indicate that OT would be a promising candidate for neonatal neuroprotection, in particular through the regulation of neuroinflammation.
More Related Videos
09:12Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding
Published on: November 14, 2018
07:27Targeting the Corticospinal Tract in Neonatal Rats with a Double-Viral Vector using Combined Brain and Spine Surgery
Published on: June 30, 2021
